<DOC>
	<DOC>NCT00608699</DOC>
	<brief_summary>To test the ability of GSK256073 to block niacin-induced flushing when GSK256073 and niacin are co-administered as single doses to HVTs.</brief_summary>
	<brief_title>A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Flushing</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Adult males between 18 and 55 years of age, inclusive. Healthy subjects Body weight &gt; 50 kg (110 pounds) and body mass index (BMI) between 19 and 31 where: Subjects with QTc &lt; 450 msec at screening History of significant cardiac arrhythmias Active peptic ulcer disease (PUD) and/or history of PUD History of gout and/or hyperuricemia History of Gilbert's syndrome History of recurrent indigestion, stomach upset or diarrhea History of other than rare (once yearly or less) flushing Recurrent skin rash or psoriasis History of kidney stones</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Flushing</keyword>
	<keyword>GSK256073A,</keyword>
	<keyword>Dose Escalation,</keyword>
	<keyword>Immediate Release Niacin,</keyword>
</DOC>